Aeromonas-Associated Diarrhea in Children Under 5 Years: The GEMS Experience

Farah Naz Qamar1, Muhammad Imran Nisar2, Farheen Quadri2

  • 1Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan. farah.qamar@aku.edu.

Insights

Aeromonas bacteria are a significant cause of moderate-to-severe diarrhea (MSD) in young children in Pakistan and Bangladesh. Risk factors include dysentery, co-infection with Shigella, and severe stunting.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Global health

Background:

  • Diarrheal diseases remain a leading cause of mortality in children under five globally.
  • Aeromonas species are increasingly recognized as potential enteric pathogens, particularly in low-resource settings.
  • Understanding the epidemiology and risk factors for Aeromonas-associated diarrhea is crucial for targeted interventions.

Purpose of the Study:

  • To investigate the clinical findings, epidemiology, and risk factors for moderate-to-severe diarrhea (MSD) associated with Aeromonas species in children aged 0-59 months.
  • To determine the significance of Aeromonas as a pathogen in MSD, controlling for other infections and sociodemographic factors.

Main Methods:

  • The study utilized data from the Global Enteric Multicenter Study, enrolling 12,110 MSD cases and 17,291 matched controls across South Asia and Sub-Saharan Africa.
  • Pooled, age-stratified conditional logistic regression models were applied to assess the association of Aeromonas infection.
  • Multivariate logistic regression analysis identified risk factors for Aeromonas positivity in MSD cases.

Main Results:

  • Aeromonas was identified as a significant pathogen in 22.2% of MSD cases in Pakistan and Bangladesh.
  • Aeromonas remained significant after adjusting for coinfecting pathogens and sociodemographic variables.
  • Increased odds of Aeromonas infection were associated with dysentery (especially in younger children), co-infection with Shigella, and severe stunting.

Conclusions:

  • Aeromonas species are a significant cause of MSD in Pakistan and Bangladesh.
  • The presence of dysentery and co-occurrence with other pathogens, particularly Shigella, are key features of Aeromonas-associated diarrhea.
  • Stunting is a significant risk factor for Aeromonas infection in young children.

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
523
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
636
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
351
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
682
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K